USFDA concludes inspection at Cipla arm InvaGen's New York facility with 'zero' observations

Cipla’s InvaGen facility in Hauppauge, New York passed a US FDA inspection October 19-22, 2026 with zero Form 483 observations

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.